
zzso is active against a variety of zzso however, severe zzso limits its zzso In our phase I study, the intravenous zzso of zzso was administered orally daily for 5 days for 2 consecutive weeks zzso every 21 zzso to children with zzso solid zzso Our objectives were to determine the zzso dose zzso zzso zzso and zzso of oral zzso and to evaluate whether zzso of zzso (8 zzso beginning 5 days before zzso and continuing throughout the course) ameliorates zzso zzso 

In separate zzso zzso doses were escalated from 15 to 45 zzso without zzso and then from 45 to 60 and 75 zzso with zzso 

Without zzso zzso was dose limiting at zzso 45 zzso zzso was not significant at any zzso The zzso was 40 zzso without zzso but 60 zzso with zzso zzso exposure to zzso at the zzso was significantly higher with zzso than without zzso zzso zzso area under the zzso zzso zzso zzso zzso standard zzso zzso zzso zzso zzso zzso v zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso P zzso zzso 

zzso administered with oral zzso is well tolerated in children and allows greater dose escalation of zzso Because zzso is a major adverse effect of both intravenous and oral zzso further evaluation of the use of zzso to zzso this adverse effect is zzso 

